Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 303

1.

Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.

Ongphiphadhanakul B, Puavilai G, Rajatanavin R.

J Med Assoc Thai. 1996 Sep;79(9):563-7.

PMID:
8996984
2.

Prospective study of bone loss in pre- and post-menopausal women on L-thyroxine therapy for non-toxic goitre.

De Rosa G, Testa A, Giacomini D, Carrozza C, Astazi P, Caradonna P.

Clin Endocrinol (Oxf). 1997 Nov;47(5):529-35.

PMID:
9425392
3.

Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L-thyroxine suppressive therapy.

Mazokopakis EE, Starakis IK, Papadomanolaki MG, Batistakis AG, Papadakis JA.

Curr Med Res Opin. 2006 Jul;22(7):1369-73.

PMID:
16834835
4.

Bone mineral density and metabolism in premenopausal women taking L-thyroxine replacement therapy.

Garton M, Reid I, Loveridge N, Robins S, Murchison L, Beckett G, Reid D.

Clin Endocrinol (Oxf). 1994 Dec;41(6):747-55.

PMID:
7889610
5.

Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis.

Franklyn J, Betteridge J, Holder R, Daykin J, Lilley J, Sheppard M.

Clin Endocrinol (Oxf). 1994 Oct;41(4):425-32.

PMID:
7955453
6.

Effect of replacement doses of thyroxine on bone mineral density.

Hanna FW, Pettit RJ, Ammari F, Evans WD, Sandeman D, Lazarus JH.

Clin Endocrinol (Oxf). 1998 Feb;48(2):229-34.

PMID:
9579237
7.

Bone mineral density in male patients with L-thyroxine suppressive therapy and Graves disease.

Jódar E, Martínez-Díaz-Guerra G, Azriel S, Hawkins F.

Calcif Tissue Int. 2001 Aug;69(2):84-7.

PMID:
11683428
8.

Thyroxine suppressive therapy decreases bone mineral density in post-menopausal women.

Kung AW, Lorentz T, Tam SC.

Clin Endocrinol (Oxf). 1993 Nov;39(5):535-40.

PMID:
8252741
9.

Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.

Guo CY, Weetman AP, Eastell R.

Clin Endocrinol (Oxf). 1997 Mar;46(3):301-7.

PMID:
9156039
10.

Skeletal integrity in men chronically treated with suppressive doses of L-thyroxine.

Marcocci C, Golia F, Vignali E, Pinchera A.

J Bone Miner Res. 1997 Jan;12(1):72-7.

11.

[Bone mineral density in patients on long-term therapy with levothyroxine].

Korsić M, Cvijetić S, Dekanić-Ozegović D, Bolanća S, Kozić B.

Lijec Vjesn. 1998 May;120(5):103-5. Croatian.

PMID:
9748785
12.
13.

Bone mineral density in pre-and post-menopausal women with affective disorder treated with long-term L-thyroxine augmentation.

Gyulai L, Bauer M, Garcia-Espana F, Hierholzer J, Baumgartner A, Berghöfer A, Whybrow PC.

J Affect Disord. 2001 Oct;66(2-3):185-91.

PMID:
11578671
14.

Bone mineral density during maintenance treatment with supraphysiological doses of levothyroxine in affective disorders: a longitudinal study.

Bauer M, Fairbanks L, Berghöfer A, Hierholzer J, Bschor T, Baethge C, Rasgon N, Sasse J, Whybrow PC.

J Affect Disord. 2004 Dec;83(2-3):183-90.

PMID:
15555712
15.

Global skeletal uptake of technetium-99m methylene diphosphonate in female patients receiving suppressive doses of L-thyroxine for differentiated thyroid cancer.

Frusciante V, Carnevale V, Scillitani A, Zingrillo M, Dicembrino F, Giannatempo GM, Ghiggi MR, Minisola S.

Eur J Nucl Med. 1998 Feb;25(2):139-43.

PMID:
9473261
16.

Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.

Baqi L, Payer J, Killinger Z, Hruzikova P, Cierny D, Susienkova K, Langer P.

Endocr Regul. 2010 Apr;44(2):57-63.

PMID:
20429634
17.

Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy.

Greenspan SL, Greenspan FS, Resnick NM, Block JE, Friedlander AL, Genant HK.

Am J Med. 1991 Jul;91(1):5-14.

PMID:
1858829
18.

Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women.

Faber J, Jensen IW, Petersen L, Nygaard B, Hegedüs L, Siersbaek-Nielsen K.

Clin Endocrinol (Oxf). 1998 Mar;48(3):285-90.

PMID:
9578817
19.

Bone mass after long-term euthyroidism in former hyperthyroid women treated with (131)I influence of menopausal status.

Serraclara A, Jódar E, Sarabia F, Hawkins F.

J Clin Densitom. 2001 Fall;4(3):249-55.

PMID:
11740067
20.

A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.

De Rosa G, Testa A, Maussier ML, Callà C, Astazi P, Albanese C.

Horm Metab Res. 1995 Nov;27(11):503-7.

PMID:
8770627
Items per page

Supplemental Content

Write to the Help Desk